11:36 AM EST - Akela Pharma, Inc. : reported a net loss for the fourth quarter ended December 31, 2009 of $14.1 million U.S., or $0.46 U.S. per share, compared to a net loss of $13.6 million U.S., $0.63 U.S. per share for the year-ago quarter. Total consolidated revenues for the fourth quarter were $3.0 million U.S., compared to $3.5 million U.S. in the prior-year quarter. Akela Pharma, Inc.
shares T.AKL are trading even at $0.09.
